PatientsLikeMe
The world’s largest personalized health network that helps people find new options for treatments, connect with others & take action to improve their outcomes.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
$26.0m Valuation: $500m | Late VC | ||
| Total Funding | 000k | ||
Related Content
In 2004, three MIT engineers, brothers Jamie and Ben Heywood, along with their friend Jeff Cole, founded PatientsLikeMe. The inspiration for this venture was deeply personal. Stephen Heywood, Jamie and Ben's brother, had been diagnosed with ALS in 1998. This life-altering event motivated the trio to create a platform where patients could share their experiences and data to improve health outcomes.
PatientsLikeMe launched its first community for ALS patients in 2006. The platform allowed users to track their health, connect with others, and contribute data to research. This innovative approach to patient care and data sharing quickly gained traction, attracting attention from both the medical community and investors.
In 2017, PatientsLikeMe experienced a significant milestone when it was acquired by iCarbonX, a Chinese health data company. This acquisition aimed to enhance the platform's capabilities by integrating advanced data analysis and artificial intelligence, further empowering patients to manage their health.
Despite challenges, including regulatory scrutiny over data privacy, PatientsLikeMe has remained committed to its mission. The company continues to evolve, focusing on expanding its communities and refining its data-driven approach to healthcare. Today, PatientsLikeMe stands as a testament to the power of empathy-driven innovation, transforming personal adversity into a platform that benefits millions worldwide.
